.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Fuji
McKesson
Accenture
Mallinckrodt
Baxter
US Army
Julphar
AstraZeneca
Cantor Fitzgerald

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019574

« Back to Dashboard
NDA 019574 describes THALITONE, which is a drug marketed by Monarch Pharms and Casper Pharma Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the THALITONE profile page.

The generic ingredient in THALITONE is chlorthalidone. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.

Summary for 019574

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 019574

Physiological EffectIncreased Diuresis

Medical Subject Heading (MeSH) Categories for 019574

Suppliers and Packaging for NDA: 019574

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THALITONE
chlorthalidone
TABLET;ORAL 019574 NDA Monarch Pharmaceuticals, Inc 61570-024 61570-024-01 100 TABLET in 1 BOTTLE (61570-024-01)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 20, 1988TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Feb 12, 1992TE:RLD:No

Expired Orange Book Patents for NDA: 019574

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Casper Pharma Llc
THALITONE
chlorthalidone
TABLET;ORAL019574-001Dec 20, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Novartis
Colorcon
Harvard Business School
Farmers Insurance
Covington
Citi
McKinsey
Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot